Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06345690 · ClinicalTrials.gov registry record
VIA Disc NP Registry 3.0
A clinical trial of Back Pain and Back Pain, Low, sponsored by VIVEX Biologics.
- Recruiting
- Registry status
- 500
- Enrollment target
- 20
- Study locations
NCT06345690: Recruiting study of Back Pain and Back Pain, Low, sponsored by VIVEX Biologics.
NCT06345690 is a study of Back Pain and Back Pain, Low that is actively recruiting participants, run by VIVEX Biologics. The registered enrollment target is 500 participants, above the 129-participant average among 37 other Back Pain trials with a reported enrollment target (288% higher). The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06345690, a study of Back Pain and Back Pain, Low, is actively recruiting participants, sponsored by VIVEX Biologics.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 20
- Study locations
Study Summary
Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.
Primary Outcome
Change in Numeric Rating Scale (NRS) scores. Eleven point pain scale used for patient self-reporting of back pain, which ranges from 0 (no pain) to 10 (the worst pain imaginable).
Conditions Studied
Interventions
- OTHER VIA Disc NP
Study Locations (20)
Colorado
- MD Pain - Englewood
- Western Rockies Interventional Pain - Grand Junction
- The Denver Spine & Pain Institute - Greenwood Village
- Premier Spine and Pain Institute - Thornton
North Carolina
- Premier Pain Solutions - Asheville
- Comprehensive Pain Consultants of the Carolinas - Hendersonville
- Crystal Coast Pain Management - Morehead City
- Crystal Coast Pain Management - New Bern
Florida
- The Orthopedic Institute - Gainesville
- Raso Pain Center - Jupiter
- Interventional Spine Care of the Palm Beaches - West Palm Beach
Louisiana
- Interventional Pain Specialists - Pain Clinic - Opelousas
- Paradigm Health System - Slidell
South Carolina
- Atlantic Coast Spine & Pain - Conway
- Renew Pain Solutions - Greenville
Arkansas
- Mocek Spine - Little Rock
Georgia
- Horizon Clinical Research - Jasper
Indiana
- The Orthopedic Research Foundation, Inc. - Fishers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-02-27 |
| Est. Completion | 2027-01-01 |
What NCT06345690 shows while recruiting
NCT06345690 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 129-participant average among 37 other Back Pain trials with a reported enrollment target (288% higher).
The record links to 3 conditions, with Back Pain appearing as the primary indexed condition, and to 1 intervention - of which VIA Disc NP is the first listed.
NCT06345690 names 20 study sites across 10 states, led by Colorado, North Carolina, Florida.
Frequently Asked Questions
What is clinical trial NCT06345690 about?
NCT06345690 is a clinical study titled "VIA Disc NP Registry 3.0". Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.
What is the current status of trial NCT06345690?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-02-27. Estimated completion is 2027-01-01.
What conditions does trial NCT06345690 study?
This clinical trial studies the following conditions: Back Pain, Back Pain, Low, Discogenic Pain.
What interventions are being tested in trial NCT06345690?
The interventions under investigation include: VIA Disc NP (OTHER).
Who is sponsoring clinical trial NCT06345690?
This trial is sponsored by VIVEX Biologics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06345690 being conducted?
This trial has 20 study locations across Arkansas, Colorado, Florida, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06345690's enrollment target sits among peer trials
500 1st of 37 higher than 37 of 37 other Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety and Efficacy of Oral Cannabis in Chronic Spine Pain
RECRUITING · Phase 3
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Dose Escalation Pilot Study to Evaluate the Safety of Alocyte for the Treatment of Facetogenic Back Pain
RECRUITING · Phase 1
-
Cannabidiol for Reduction of Brain Neuroinflammation
RECRUITING · Phase 2
-
CARES-Spine (Comprehensive Analgesic, Recovery, and Education Support for Spine Surgery) Trial
RECRUITING · Phase 3
-
Moderators and Mediators (M & M Trial) of Psychosocial Treatments of Chronic Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI